F Joseph McClernon
Overview
Explore the profile of F Joseph McClernon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Giummo R, Oliver J, McClernon F, Sweitzer M
Drug Alcohol Depend
. 2024 Jul;
262:111393.
PMID: 39024797
Background: Switching to Very Low Nicotine Content (VLNC) cigarettes reduces toxicant exposure and nicotine dependence, and may improve smoking cessation. However, non-compliance with VLNCs is often high, which may reduce...
12.
Hatsukami D, Jensen J, Carroll D, Luo X, Strayer L, Cao Q, et al.
Lancet Reg Health Am
. 2024 Jun;
35:100796.
PMID: 38911348
Background: Reducing cigarette addictiveness has the potential to avert millions of yearly tobacco-related deaths worldwide. Substantially reducing nicotine in cigarettes decreases cigarette consumption, but no large clinical trial has determined...
13.
Fuemmeler B, Dahman B, Glasgow T, Barsell D, Oliver J, Zhang J, et al.
Nicotine Tob Res
. 2024 May;
26(11):1530-1537.
PMID: 38818778
Introduction: Identifying healthcare utilization and costs associated with active and passive smoking during pregnancy could help improve health management strategies. Aims And Methods: Data are from the Newborn Epigenetics STudy...
14.
Glauber K, Turner A, Sperling J, McClernon F
J Clin Transl Sci
. 2024 Mar;
8(1):e49.
PMID: 38510691
Translation of critical and broadly impactful health advancements is stymied by insufficient scientific scrutiny of barriers and roadblocks in the process. The Clinical & Translational Science Award (CTSA) funding opportunity...
15.
Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork J, Claus E, et al.
JAMA Psychiatry
. 2024 Feb;
81(4):414-425.
PMID: 38324323
Importance: In the last 25 years, functional magnetic resonance imaging drug cue reactivity (FDCR) studies have characterized some core aspects in the neurobiology of drug addiction. However, no FDCR-derived biomarkers...
16.
Rubenstein D, Carroll D, Denlinger-Apte R, Ross J, McClernon F
Subst Use Addctn J
. 2024 Jan;
45(1):54-64.
PMID: 38258860
Background: The prevalence of combusted cigarette (CC) smoking among older adults is stagnant, with 0 declines attributable to e-cigarette (EC) use. Given that normative beliefs are associated with quitting and...
17.
Smoking Quit Attempts and Associated Factors Among Rural Adults Who Smoke Daily in the United States
Bittencourt L, Rubenstein D, Noonan D, McClernon F, Carroll D
Nicotine Tob Res
. 2023 Dec;
26(7):948-953.
PMID: 38085266
Introduction: Rural American communities are heavily affected by tobacco-related health disparities. This study aims to evaluate the prevalence of quit attempts (QAs) and factors that promote or impede QA among...
18.
Rubenstein D, McClernon F, Powers J, Aston E, Keefe F, Sweitzer M
Addict Behav
. 2023 Jul;
146:107814.
PMID: 37499280
Introduction: Rates of tobacco and cannabis use are disproportionately high among individuals with pain, and evidence suggests that pain may engender greater likelihood of substance co-use, yielding additive risk. This...
19.
Rubenstein D, Pacek L, Smith C, McClernon F, Enyioha C, Vilardaga R
Drug Alcohol Depend
. 2023 May;
248:109943.
PMID: 37247521
Background: Racial/ethnic minority status and mental illness independently drive inequity in cigarette smoking and related morbidity. Racial/ethnic minority groups suffer a disproportionate burden of tobacco-related diseases. People with serious mental...
20.
Rubenstein D, Denlinger-Apte R, Ross J, Carroll D, McClernon F
Tob Control
. 2023 May;
33(e2):e266-e269.
PMID: 37137702
Introduction: The prevalence of cigarette smoking among adults aged ≥55 has remained stagnant over the past decade. National data modelling suggests no reduction in cigarette smoking prevalence attributable to e-cigarette...